UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

Stage 2 prostate adenocarcinoma is localized, with a nearly 100%, five-year relative survival rate. Diagnosis uses the TNM system, PSA levels and Gleason score to determine cancer stage and risk.

A silent killer that is the second leading cause of death among American men, prostate cancer is a disease that has recently come to the forefront of medical research. Studies and new reviews are ...

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting ...

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing ...

When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...

What happens if PSA levels start rising after surgery or radiation for prostate cancer? Up to a third of men treated for the disease will eventually confront this problem. If there's no accompanying ...

What Is Akeega, and Why Does It Matter? Akeega is a dual-action tablet combining two medicines — niraparib and abiraterone acetate — that has been approved by the FDA in combination with prednisone (a ...

Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing ...

The analysis – reported at the European Association of Urology (EAU) annual congress in London, UK – shows that it is "no longer rational to reject prostate cancer screening on one hand while ...